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[6_TD$DIFF]Abstract
The homo- and hetero-tetrameric channel complexes formed by transient
receptor potential cation channel, subfamily M, member 6 (TRPM6) and
7 (TRPM7) (collectively referred to as TRPM6/TRPM7 channels in this study)
are the major regulators of cellular magnesium uptake, yet the exact roles of
TRPM6/TRPM7 channels and cellular magnesium homeostasis during
development are poorly understood. Here, we report a novel small molecule
Mesendogen (MEG) which robustly induces nearly homogeneous (≥85%)
mesoderm and definitive endoderm (DE) differentiations of human embryonic
stem cells (hESCs) in combination with growth factors. A kinome screen
followed by loss-of-function experiments identified TRPM6 as the biological
target of MEG. We demonstrated that MEG functions by inhibiting TRPM6/
TRPM7 magnesium channel activity, as MEG reduced intracellular magnesium
level, while TRPM6/TRPM7 channel modulation and magnesium-withdrawal
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phenocopied MEG at enhancing mesoderm and DE differentiations. This study
discovers a robust chemical enhancer of hESC directed differentiation, and
uncovers a novel regulatory role of cellular magnesium homeostasis during early
embryonic cell fate specification.
Keywords: Biological sciences, Early embryonic development, Stem cells,
Cell differentiation
1. Introduction
Transient receptor potential cation channel, subfamily M, member 6 (TRPM6)
and 7 (TRPM7) are known as “channel kinases” in that they contain both an
intracellular kinase domain and a transmembrane channel domain (Chubanov
et al., 2005a; Chubanov et al., 2007; Chubanov et al., 2006; Chubanov et al.,
2005b; Chubanov et al., 2004; Schlingmann et al., 2007). The homo- and
hetero-tetrameric channel complexes formed by TRPM6 and TRPM7 are
believed to be the major ion channels responsible for cellular magnesium import
(Chubanov et al., 2005b; Chubanov et al., 2004; Schlingmann et al., 2007).
Although the role of Mg2+ in maintaining normal physiological functions of
various adult organs and tissues has been well-established, its function during
early embryonic development remains poorly understood. Mg2+ deficiency has
been shown to cause severe developmental defects in Xenopus laevis and rats
(Hurley et al., 1976; Miller and Landesman, 1977; Wang et al., 1971), and has
been linked to birth defects in humans, in particular to the neural tube closure
defect spina bifida (Groenen et al., 2004). Results from loss-of-function studies
of TRPM6/TRPM7 channel corroborate with these findings, as mice defective
inTRPM6 displayed embryonic mortality and neural tube defects (Walder et al.,
2009), while TRPM7-knockout mice died before day 7.5 of embryogenesis (E7.5)
(Jin et al., 2008; Jin et al., 2012). In Xenopus laevis, TRPM7 depletion by
morpholino resulted in neural tube closure defect and dorsal-flexure, with the
development of anterior structures of the embryo severely reduced or missing; this
phenotype was partially rescued by Mg2+ supplementation or forced expression of
TRPM6 (Liu et al., 2011). The dysregulation of noncanonical Wnt pathway or
planar cell polarity (PCP) pathway, the pathway regulating convergent extension
movement during gastrulation, has been proposed as the underlying cause of the
neural tube closure defect phenotype observed in Xenopus laevis (Liu et al., 2011),
although not without debate (Komiya et al., 2014; Walder et al., 2009)
(Discussion). These observations suggest a potentially key regulatory role of Mg2+
during early embryonic development, toward which controversy remains and a
thorough understanding has not been acquired.
In this study, through a small scale chemical screen, we discovered a novel
small molecule Mesendogen (MEG for short) that robustly enhanced the growth
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factor-induced mesoderm and DE differentiations of human embryonic
stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) to
near-homogeneity (≥85%). Using target identification techniques followed by
functional validations, we identified TRPM6 as the biological target of MEG.
We further demonstrated that MEG treatment in hESCs effectively reduced
cellular magnesium level, and that inhibition of the magnesium-importing
activity of TRPM6/TRPM7 channel complexes by known channel modulators
and withdrawal of Mg2+ in differentiation medium gave rise to similar
differentiation-enhancing phenotypes as compared to MEG. These data suggest
that MEG exerts its biological function by acting as an inhibitor of TRPM6/
TRPM7 channels and, subsequently, by modulating cellular Mg2+ uptake. This
study for the first time uncovers a regulatory role of Mg2+ in embryonic cell
fate determination, in addition to its previously proposed role in regulating
cell movement during gastrulation (Liu et al., 2011).
2. Results
2.1. Small scale chemical screening identified a novel small
molecule that induces mesoderm and endoderm, but not neural
differentiation of human embryonic stem cells (hESCs)
We previously conducted a high-throughput chemical screening and found 29
bioactive small molecules that potently disrupt hESC pluripotency (Geng et al.,
2015). Using this compound collection we conducted a small scale chemical
screen (Materials and Methods) to search for small molecules that specifically
induce mesoderm and DE differentiations, and identified compound [3_TD$DIFF]6528694
(N-({[2-chloro-5-(trifluoromethyl) phenyl]amino}carbonothioyl)-4-
isopropylbenzamide; Fig. 1A). The colony integrity of hESCs was lost after
treated with [3_TD$DIFF]6528694 at 10 μM for 4 days, as evidenced by cells within the
colonies spread out and migrated away from each other (Fig. 1B). A 7-day
treatment of [3_TD$DIFF]6528694 in hESCs maintained under a pluripotency culture
condition (“mTeSR1” condition hereafter) (Ludwig et al., 2006) induced
elevated protein expressions of mesoderm markers T (Brachuary) and EOMES
(Eomesodermin) and DE markers SOX17 and FOXA2, but not neural-specific
markers PAX6 and SOX1 (Fig. 1B). Meanwhile pluripotency was disrupted as
expected, shown by downregulations of the pluripotency markers OCT4 and
SOX2 (also a neural differentiation marker) (Fig. 1C). We thus name this
compound Mesendogen, short for Mesoderm and Definitive Endoderm Inducing
Reagent, and hereafter refer to this molecule as MEG for short.
The sole fact that lineage-specific markers were elevated upon MEG treatment
cannot prove that mesoderm or DE progenitors have been successfully
generated. To prove the existence of such a population, one must demonstrate
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the emergence of a distinct cell population that expresses progenitor markers
at the single cell level. However, MEG treatment alone was insufficient to induce
such a distinct mesoderm progenitor population: when incubated with hESCs in a
growth factor-free mesoderm basal differentiation medium (Materials and Methods),
MEG marginally increased T expression in the overall population, but failed to drive
the differentiation of a distinct T+ population compared to the DMSO control, as
shown by FACS analysis (Fig. 1D). We therefore decided to test whether MEG
could enhance the efficiencies of growth factor-guided mesoderm and DE
differentiation protocols at generating mesoderm and DE progenitors.
2.2. MEG induces nearly homogeneous mesoderm
differentiation in combination with growth factors
To test the effect of MEG in growth factor-induced mesoderm differentiation, we
first derived a 2-dimensional (2-D) growth factor-guided mesoderm induction
protocol (Fig. 2A and Materials and Methods; “A-BVF” method hereafter)
modified based on previous publications (Bernardo et al., 2011; Evseenko et al.,
2010; Yu et al., 2011). Briefly, Activin A (A), bone morphogenetic protein 4
(BMP4; B), vascular endothelial growth factor (VEGF; V), and basic fibroblast
growth factor (bFGF; F) were used to drive differentiation; cells were analyzed
after 1.5–2 days of induction (Fig. 2A and Materials and Methods). Using this
method, we found that mesoderm differentiation efficiencies highly depended on
[(Fig._1)TD$FIG]
Fig. 1. Compound [3_TD$DIFF]6528694 (Mesendogen) induces hESC mesoderm and endoderm
differentiation. (A) Chemical structure of compound [3_TD$DIFF]6528694 (Mesendogen or MEG). (B) Phase
contrast images of H1 hESCs treated with DMSO and [3_TD$DIFF]6528694 (MEG, 10 μM) for 4 days in
mTeSR1 medium. Scale bar: 100 μm. (C) Western blotting of endoderm markers SOX17 and
FOXA2, mesoderm markers T and EOMES, neural-specific markers SOX1 and PAX6, and
pluripotency markers OCT4 and SOX2 in undifferentiated H9 hESCs (Control) or H9 hESCs treated
with [3_TD$DIFF]6528694 (MEG, 10 μM) for 7 days while maintained in mTeSR1 medium. α-TUBULIN was
used as a loading control. (D) FACS analysis of T in H9 hESCs treated with DMSO and MEG
(5 μM) for 4 days. n = 4 independent experiments.
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the initial plating densities of hESCs: the lowest plating density tested (0.1 × 105
cells/cm2) gave the highest yield of T+EOMES+ cells [7_TD$DIFF](73.4 ± 2.3% by FACS;
Fig. 2B) which represent mesoderm progenitors; this efficiency quickly dropped to
[8_TD$DIFF]<5% at and above 0.5 × 105 cells/cm2 (Fig. 2B).
We then added MEG to the A-BVF induction protocol, either by directly
combining with the growth factors (Fig. 2A; “MEG+A-BVF” or “combination”
[(Fig._2)TD$FIG]
Fig. 2. MEG induces nearly homogeneous mesoderm differentiation in combination with the
A-BVF condition. (A) Schematic overviews of mesoderm differentiation conditions used in this study.
(B) Summary of FACS results showing the percentages of T+EOMES+ population acquired after 2 days
of mesoderm differentiation of H9 and H1 hESCs under various plating densities and differentiation
conditions. Results from six independent experiments (n = 6) are shown as mean ± SD; 3–4 data points
were collected and analyzed for each condition. (C) FACS analysis of T and EOMES in H9 hESCs
treated with mesoderm differentiation conditions including A-BVF, MEG+A-BVF, and MEG->A-BVF.
Cells were plated at 0.25 × 105 cells/cm2. (D) Immunofluorescent staining of T (red) and EOMES
(green) in H1 hESCs induced to undergo mesoderm differentiation for ∼1.5 days under various
conditions. Nuclei were stained with DAPI (blue). Cells were plated at 0.25 × 105 cells/cm2 for
A-BVF condition, 0.75 × 105 cells/cm2 for MEG+A-BVF condition, and 1.0 × 105 cells/cm2
for MEG->A-BVF condition. (E) Western blotting of T and EOMES in H9 hESCs induced to
undergo mesoderm differentiation for 2 days under A-BVF and MEG->A-BVF conditions. Cells
cultured in mesoderm basal medium without growth factors were used as a control (Blank).
Cells were plated at 1.0 × 105 cells/cm2. α-TUBULIN was used as a loading control.
(F) Quantitative-PCR analysis of mesoderm markers in H9 hESCs under A-BVF and
MEG+A-BVF conditions for 2 days. All values were normalized to the mRNA level (=1) in cells
cultured in mesoderm basal medium without growth factors. Each bar represents the mean ± SD
(error bars). n = 2 independent experiments. ACTB (β-actin) was used as a loading control.
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condition hereafter) or by pre-incubating in mTeSR1 medium for 24 hours
before starting the growth factor treatments (Fig. 2A; “MEG->A-BVF” or
“pre-treatment” condition hereafter). Both approaches dramatically improved the
induction efficiencies of A-BVF in all plating densities tested (Fig. 2B). Most
notably, the combination condition enhanced the differentiation efficiency
(measured by percentage of T+/EOMES+ cells) at the density of 0.1 × 105 cells/cm2
from 73.4 ± 2.3% for the A-BVF condition to an average of 82.7 ± 2.6%,
whereas the pre-treatment condition dramatically enhanced the efficiency at
0.25 × 105 cells/cm2 from 27.4 ± 9.0% to 88.4 ± 4.0% (Fig. 2B). An example of
nearly homogeneous mesoderm differentiation at 0.25 × 105 cells/cm2 plating density
under both the pre-treatment condition and the combination condition is shown in
Fig. 2C. Similar results were acquired through immunofluorescence staining
(Fig. 2D) and Western blotting (Fig. 2E) using the same markers T and EOMES, and
through qPCR using a range of mesoderm markers including T, EOMES, MIXL1,
EVX1, TBX6, HAND1, MESP1, and MEOX1 (Fig. 2F).
We find one technical question particularly worth noting for the FACS analyses
which is that undifferentiated hESCs already possess significant background
signals for T and EOMES. If isotype controls were used to set up quadrants for the
dot plots, these background signals will lead to an extremely high false positive
rate for the detection of T+EOMES+ population (98.42% T+EOMES+; Fig. 3A).
Thus, undifferentiated hESCs stained for T and EOMES, instead of isotype IgG
controls, were used as gating controls for mesoderm-differentiation FACS analyses
performed in this study (unless otherwise specified) to ensure a stringent
quantification of the differentiation efficiencies (Materials and Methods).
The mesoderm differentiation-enhancing effect of MEG is robust and is not
limited to hESCs or to the A-BVF differentiation condition. MEG effectively
enhanced the mesoderm differentiation efficiency of a human induced
pluripotent stem cell (hiPSC) line MMW2 (Mali et al., 2010) in a similar
fashion as compared to its effect in hESCs (Fig. 3B). MEG also improved the
efficiencies of variations of mesoderm induction conditions adopted from
reported methods with modifications, such as BVF condition (Bernardo et al.,
2011) (BMP4, VEGF, and bFGF; Fig. 3C) and BF condition (Bernardo et al.,
2011; Yu et al., 2011) (BMP4 and bFGF; Fig. 3D). Detailed protocols for these
conditions are described in Materials and Methods.
2.3. MEG induces nearly homogeneous definitive endoderm
differentiation in combination with growth factors
To test whether MEG enhances growth factor-induced DE differentiation in a
similar fashion as compared to its effects in mesoderm differentiation, we first
established a 2-D growth factor-guided DE induction protocol (Fig. 4A and
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Fig. 3. MEG enhances mesoderm differentiation of hiPSCs and of variations of mesoderm
induction conditions. (A) FACS analysis of PE and APC in H9 hESCs cultured in mTeSR1
medium. Cells were stained with T-PE and EOMES-APC antibodies (T-PE/EOMES-APC) or
non-specific IgG isotype control antibodies conjugated with the same fluorophores (isotype control).
Isotype IgG, when used as a gating control, gave rise to a high percentage of false-positive cells in
the undifferentiated mTeSR1 culture (98.42% PE+APC+ in the T-PE/EOMES-APC stained sample).
n > 10 independent experiments. (B) FACS analysis of T and EOMES in MMW2 hiPSCs
differentiated in A-BVF, MEG+A-BVF, and MEG->A-BVF conditions for 2 days. Cells were
plated at 0.5 × 105 cells/cm2 for A-BVF and MEG->A-BVF conditions and 0.25 × 105 cells/cm2 for
MEG+A-BVF condition. Cells cultured in mTeSR1 medium were used as a gating control. n = 2
independent experiments. (C) FACS analysis of T in H1 hESCs differentiated in BMP4 (10 ng/ml),
VEGF (10 ng/ml), and bFGF (20 ng/ml) (BVF condition) for 1.5 days, with or without MEG
(10 μM) pre-treatment. n = 2 independent experiments. (D) FACS analysis of T in H1 hESCs
differentiated in BMP4 (10 ng/ml) and bFGF (20 ng/ml) (BF condition) for 1.5 days, with or
without MEG pre-treatment. n > 5 independent experiments.
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Materials and Methods; “AWS” method hereafter) designed based on reported
methods (Borowiak et al., 2009; D'Amour et al., 2005) with modifications.
Briefly, Activin A (A), WNT3A (W), and increasing concentrations of fetal
bovine serum (S) were applied to drive differentiation; cells were analyzed after
5–7 days of induction (Fig. 4A and Materials and Methods). DE differentiation
efficiencies were measured by FACS analyses by quantifying the percentage of
[(Fig._4)TD$FIG]
Fig. 4. MEG induces nearly homogeneous definitive endoderm differentiation in combination
with the AWS condition. (A) Schematic overviews of definitive endoderm differentiation conditions
used in this study. (B) Summary of FACS results showing the percentages of SOX17+FOXA2+
population acquired after 7 days of definitive endoderm differentiation of H1 and H9 hESCs under
various plating densities and differentiation conditions. Results from six independent experiments (n = 6)
are shown as mean ± SD; 3–5 data points were collected and analyzed for each condition. (C) FACS
analysis of SOX17 and FOXA2 in H1 hESCs treated with definitive endoderm differentiation conditions
including AWS, MEG+AWS, and MEG->AWS for 7 days. Cells were plated at 1.0 × 105 cells/cm2.
(D) Immunofluorescent staining of SOX17 (red) and FOXA2 (green) in H9 hESCs induced to undergo
definitive endoderm differentiation under the MEG->AWS condition for 1, 3, and 7 days. Nuclei were
stained with DAPI (blue). Scale bar: 100 μm. (E) Western blotting of SOX17, FOXA2, CER1, and AFP
in H9 hESCs induced to undergo definitive endoderm differentiation under AWS, MEG+AWS, and
MEG->AWS conditions for 7 days. Cells cultured in mTeSR1 medium were used as a control
(mTeSR1). Cells were plated at 0.25 × 105 cells/cm2 for the AWS condition, 1.0 × 105 cells/cm2 for the
MEG+AWS condition, and 1.5 × 105 cells/cm2 for the MEG->AWS condition. α-TUBULIN was used
as a loading control. (F) Quantitative-PCR analysis of endoderm markers in H9 hESCs under AWS and
MEG->AWS conditions for 5 days. All values were normalized to the mRNA level (=1) in cells cultured
in mTeSR1 medium. Each bar represents the mean ± SD (error bars). n = 2 independent experiments.
ACTB (β-actin) was used as a loading control.
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SOX17+FOXA2+ cells which represent DE progenitors. Using this method we
found that, similar to mesoderm differentiation, DE differentiation efficiencies
also highly depended upon the initial plating densities, and lower densities
again gave rise to higher differentiation efficiencies (Fig. 4B). The highest
differentiation efficiencies induced by the AWS condition were given by cells
plated at 0.25 × 105 cells/cm2 (36.1 ± 26.2%; Fig. 4B).
We then added MEG to the AWS condition either by pre-treatment (Fig. 4A;
“MEG->AWS” or “pre-treatment” condition) or in combination with the
growth factors (Fig. 4A; “MEG+AWS” or “combination” condition). Both
approaches significantly boosted differentiation efficiencies for all plating
densities tested (Fig. 4B). Most notably, both treatments dramatically
enhanced the differentiation efficiency at the density of 1.0 × 105 cells/cm2,
from 11.8 ± 8.7% SOX17+FOXA2+ for the AWS condition, to an average of
72.7 ± 19.7% for the combination condition and 85.9 ± 6.1% for the pre-treatment
condition (Fig. 4B). In some experiments, MEG treatments dramatically enhanced
the efficiencies of DE progenitor differentiation to >90% under this optimum
plating density, as shown by FACS analysis (Fig. 4C). A time course analysis of
the MEG->AWS condition by immunofluorescence staining of SOX17 and
FOXA2 is shown in Fig. 4D, again demonstrating a nearly homogeneous SOX17
+FOXA2+ culture on day 7. The expressions of several other endoderm-specific
markers including CER1, GATA4, GATA6, and GSC were also significantly
enhanced by MEG, as shown by Western blotting (Fig. 4E) and qPCR (Fig. 4F).
It should be noted that SOX17, FOXA2, and all the other endoderm markers
discussed so far are pan-endoderm markers that are expressed in both definitive
and extra-embryonic endoderm lineages (Borowiak et al., 2009). To rule out the
possibility of extra-embryonic endoderm (ExEn) differentiation in this method,
we examined the expressions of ExEn-specific markers AFP (α-fetoprotein) and
SOX7 using Western blotting (Fig. 4E) and qPCR (Fig. 4F). Results showed no
significant elevation of AFP and SOX7 in all differentiation conditions examined
(Fig. 4E and F), verifying the DE-lineage identity of the differentiated progenies.
Similar to mesoderm-differentiation analyses, undifferentiated hESCs stained for
SOX17 and FOXA2, instead of isotype IgG controls, were used as gating
controls to prevent false positive measurement of the differentiation efficiency
(46.74% false positive SOX17+FOXA2+ were detected if gate was setup by
isotype IgG controls; Fig. 5A and Materials and Methods). A similar DE
differentiation-enhancing effect of MEG was observed in the hiPSC line MMW2
(Fig. 5B). Moreover, MEG also improved the efficiencies of variations of DE
induction conditions adopted from published protocols with modifications, such
as AW-B27 (Norrman et al., 2013) (serum replaced by B-27 supplement;
Fig. 5C) and AW-ITS (Cai et al., 2007) (serum replaced by ITS supplement;
Fig. 5D) conditions (Materials and Methods).
Article No~e00046
9 http://dx.doi.org/10.1016/j.heliyon.2015.e00046
2405-8440/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
[(Fig._5)TD$FIG]
Fig. 5. MEG enhances definitive endoderm differentiation of hiPSCs and of variations of definitive endoderm induction conditions. (A) FACS analysis of SOX17 and FOXA2 in H9
hESCs cultured in mTeSR1 medium. Cells were stained with SOX17-APC and FOXA2-Alexa488 antibodies (SOX17-APC/FOXA2-Alexa488) or non-specific IgG isotype control antibodies
conjugated with the same fluorophores (isotype control). Isotype IgG, when used as a gating control, gave rise to a high percentage of false-positive cells in the undifferentiated mTeSR1
culture (∼50% APC+/Alexa488+ and ∼98% Alexa488+ in the SOX17-APC/FOXA2-Alexa-488 stained sample). n > 10 independent experiments. (B) FACS analysis of SOX17 and FOXA2
in MMW2 hiPSCs cells induced to undergo definitive endoderm differentiation under AWS, MEG+AWS, and MEG->AWS conditions for 7 days. Cells were plated at 1.0 × 105 cells/cm2
for AWS and MEG+AWS conditions, and at 0.5 × 105 cells/cm2 for MEG->AWS condition. Cells cultured in mTeSR1 medium were used as a gating control. n = 2 independent
experiments. (C) FACS analysis of SOX17 and FOXA2 in H9 hESCs induced to undergo definitive endoderm differentiation for 5 days in AW-B27, MEG+AW-B27, and MEG->AW-B27
conditions. B-27 supplement was used in these conditions instead of serum. Cells were plated at 1.0 × 105 cells/cm2. n > 3 independent experiments. (D) FACS analysis of SOX17 and
FOXA2 in H9 hESCs induced to undergo definitive endoderm differentiation for 5 days in AW-ITS, MEG+AW-ITS, and MEG->AW-ITS conditions. ITS (insulin, transferrin, and selenium)
supplement was used in these conditions instead of serum. Cells were plated at 2.0 × 105 cells/cm2. n = 2 independent experiments.
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2.4. MEG functions at the onset of mesoderm and DE
differentiations but with no effect observed on Nodal and Wnt
signaling
Based on the results that the pre-treatment conditions of MEG in both
mesoderm and DE differentiations gave rise to similar, if not better,
differentiation efficiencies compared to the combination conditions, we
hypothesized that MEG may function by triggering a pathway (or pathways)
involved only in the very early phase of mesoderm and DE inductions. Indeed,
for both MEG+A-BVF (Fig. 6A) and MEG+AWS (Fig. 6B) conditions, the
differentiation-enhancing effects of MEG were nearly completely lost when
MEG was added starting from day 1 of differentiation instead of from day 0,
strongly supporting this hypothesis.
As MEG enhances both mesoderm and DE differentiations, we further
hypothesized that the biological pathway targeted by MEG may be involved in
the developmental stage immediately upstream of mesoderm and DE
specifications, namely primitive streak formation. As Nodal/TGF-β signaling
pathway and canonical Wnt pathway are known to be essential for primitive
streak induction (Conlon et al., 1994; Liu et al., 1999), we set out to examine
the effect of MEG on these pathways. Overnight incubation of MEG was
applied to mimic the pre-treatment conditions for mesoderm and DE
differentiations. To test the effect of MEG on Nodal/TGF-β pathway, Activin
A was added for various lengths of time after overnight incubation of MEG.
Pre-treatment of MEG at a wide range of doses all failed to vary the signaling
strength of Nodal/TGF-β pathway, quantified by the level of Phospho-SMAD2
(Fig. 6C). A time course analysis after overnight incubation and with continues
addition of MEG during Activin A treatment also showed no effect of MEG on
the maintenance of Nodal/TGF-β signaling over time (Fig. 6D). On the other
hand, overnight treatment of MEG showed no effect on the activation
of canonical Wnt signaling pathway, quantified by the level of
Phospho-β-CATENIN (Fig. 6E).
2.5. In vitro kinome screen and functional validations identified
TRPM6 as the biological target of MEG
To investigate the molecular mechanism of MEG, we employed a series of
target identification and validation techniques. We first conducted structure-
activity relationship (SAR) assays, a technique used to determine structural
module(s) within a bioactive small molecule that is/are responsible for its
biological activity and to identify the overall chemical structure which possesses
the strongest bioactivity. In brief, a number of structurally similar compounds
with the same basic chemical backbone but modified by different side groups at
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Fig. 6. MEG functions at the onset of mesendoderm differentiation but shows no effect on Nodal
and Wnt signaling. (A) FACS analysis of T and EOMES in H9 hESCs differentiated in MEG->
A-BVF, A-BVF, and delayed MEG+A-BVF (with MEG added on day 1 instead of day 0) conditions.
(B) FACS analysis of SOX17 and FOXA2 in H1 hESCs differentiated for 7 days in AWS condition and
MEG+AWS condition with MEG added on day 0 or day 1. Cells were plated at 1.5 × 105 cells/cm2.
(C) Western blotting of Phospho-SMAD2 (P-SMAD2) in H1 hESCs pre-treated with DMSO and MEG
in mTeSR1 medium overnight, followed by 0.5 hr treatment of Activin A (10 ng/ml) in RPMI-1640
medium. SMAD2/3 was used as a loading control. n = 3 independent experiments. (D) Western blotting
of Phospho-SMAD2 (P-SMAD2) in H1 hESCs untreated or pre-treated with DMSO and MEG (10 μM)
in mTeSR1 medium overnight, followed by treatment of Activin A (10 ng/ml) in RPMI-1640 medium
with DMSO and MEG for various lengths of time. SMAD2/3 was used as a loading control.
(E) Western blotting of Phospho-β-CATENIN (P-β-CATENIN) in H1 hESCs untreated (Control) or
treated with MEG at 10 μM and 25 μM in mTeSR1 medium overnight. β-CATENIN was used as a
loading control. n = 2 independent experiments.
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different positions (serially numbered as MEG analogs (MA) 1–12; Fig. 7A
shows the closest analogs of MEG, whereas Fig. 7B shows the more distant
analogs) were purchased and assayed side-by-side with MEG under
differentiation conditions for their differentiation-enhancing capabilities.
Mesoderm differentiation was used for the tests as its duration is significantly
shorter than DE differentiation. At 5 μM two structural analogs of MEG, MA1
and MA2, showed observable enhancement effects on mesoderm differentiation,
although insignificant compared to the effect of MEG tested alongside at 1 μM
(Fig. 8A); none of the other structural analogs tested showed significant
enhancement effect at 5 μM (Fig. 8A). Both MA1 and MA2 showed stronger
effects when tested at a higher dose of 20 μM, confirming their differentiation-
enhancing activities, although MEG was still the most active at 10 μM
(Fig. 8B). Both compounds and MEG share a –C(CH3)2 group at position R3 of
their structures, which appears to be a crucial side group for their activities as
compound MA4, missing only the –C(CH3)2 group compared to MEG, showed
[(Fig._7)TD$FIG]
Fig. 7. Structural analogs of MEG. (A) Basic chemical structures of MEG and its close analogs
(MA1–MA5). Labels R1, R2, and R3 mark the positions of chemical groups that modify the
backbone structure shared by the analogs. (B) Chemical structures for MEG analogs 6–12
(MA6–MA12) tested in SAR analysis.
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[(Fig._8)TD$FIG]
Fig. 8. SAR analysis identified MEG as the most potent compound among close structural analogs. (A) FACS analysis of T in H9 hESCs differentiated for 2 days in A-BVF condition
in combination with DMSO, MEG (1 μM), or chemical analogs of MEG (5 μM, except 1 μM for MA12). Cells maintained in basal differentiation medium for 2 days but without the addition
of growth factors (Blank) generally show similar levels of background signals for T and EOMES stainings as in undifferentiated hESCs (data not shown) and were used as a gating control.
n = 2 independent experiments. (B) FACS analysis of T and EOMES in H9 hESCs differentiated for 2 days in A-BVF condition with or without MEG (10 μM), MA1 (20 μM), and MA2
(20 μM). Cells maintained in basal differentiation medium but without the addition of growth factors (Blank) were used as a gating control. n = 2 independent experiments.
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no differentiation-inducing capability under the condition tested (Fig. 8A). On
the other hand the –CF3 and –Cl groups at positions R1 and R2, respectively,
could be removed while keeping a significant part of MEG's bioactivity (MA1
and MA2; Fig. 8A and B), although interestingly, adding back a –OH group at
R2 seemed to have abolished the remaining activity of MA2 (MA3; Fig. 8A).
Because results from SAR analysis showed that MEG remains to be the most
potent molecule within all of its commercially available structural analogs, we
decided to continue using MEG for all subsequent target identification and
validation experiments.
Kinases are important regulators of biological pathways and are involved in a
wide variety of biological processes; their roles during cellular differentiation
and embryonic development are being actively studied (Choi et al., 2007;
Oh et al., 2009; Tian et al., 2009). The enzymatic activities of kinases can be
inhibited at their ATP-binding sites by small planar compounds with high
aromatic contents but no stereocenters (Huigens et al., 2013), which are
characteristics shared by MEG. We thus postulated that MEG may function by
targeting ATP-binding site-containing proteins such as kinases, and applied
MEG to an in vitro kinase screen using a commercial service (KINOMEscan by
DiscoveRx; Materials and Methods). A total of 456 kinases were analyzed with
results summarized in Fig. 9A, in which a lower Percent-of-Control (%Ctrl)
value indicates a stronger interaction between the test compound and a kinase.
Only two kinases gave %Ctrl values lower than 60, with a %Ctrl value of 50 for
TRPM6 and 47 for NEK3 (Fig. 9B). The TRPM7 channel kinase was not
included in this screen.
As numerous studies have indicated a potential regulatory role of TRPM6/
TRPM7 channels during embryonic development, we hypothesized that TRPM6
may be the biological target of MEG. To test this hypothesis we first confirmed
the expression of TRPM6 in undifferentiated hESCs. TRPM6 gene encodes 7
isoforms via alternative splicing, with isoforms TRPM6a, TRPM6b, and
TRPM6c containing the transmembrane channel domain and the kinase domain,
isoforms TRPM6-kinase-1, -2, and -3 containing only the kinase domain, and
the testes-specific isoform TRPM6t containing only the transmembrane domain
(Chubanov et al., 2004). RT-PCR analysis using isoform-specific primers
(Chubanov et al., 2004) showed that the kinase- and channel domain-containing
isoforms TRPM6a and TRPM6b, but not the other isoforms of TRPM6, were
expressed in undifferentiated hESCs (Fig. 9C). TRPM7, the ubiquitously
expressed member of the TRPM protein family (Chubanov et al., 2005a), was
also expressed in hESCs as expected (Fig. 9C).
We then tested whether the inhibition of TRPM6 expression can mimic the
effect of MEG on hESC differentiation. As prolonged depletion of cellular Mg2+
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by a persistent TRPM6 knock down during differentiation will ultimately lead
to cell death, to avoid the selective loss of TRPM6 knock-down cells during
differentiations and thus inaccurate measurements of the differentiation
efficiencies, we delivered the shRNA constructs by transient transfections
rather than stable lentiviral infections at the beginning of each experiment.
[(Fig._9)TD$FIG]
Fig. 9. TRPM6 is the biological target of MEG. (A) Summary of KINOMEscan result. Lower
values of %Ctrl indicate stronger interactions between the test compound and the kinases. (B) %Ctrl
values for TRPM6 and NEK3 as detected in KINOMEscan. (C) Agarose gel electrophoresis showing
RT-PCR amplification of undifferentiated H1 hESCs using TRPM6 isoform-specific PCR primers.
White arrows point to the expected positions of the amplified bands. Note that the band shown in
the “t” lane is not in the correct position and thus does not indicate expression of the t isoform. a:
TRPM6a; b: TRPM6b; c: TRPM6c; k1: TRPM6-kinase-1; k2: TRPM6-kinase-2; k3: TRPM6-kinase-
3; t: TRPM6t. (D) FACS analysis of T and EOMES in H9 hESCs transfected with NT shRNA and
TRPM6 shRNAs and differentiated under A-BVF condition for 2 days. n = 4 independent
experiments. (E) FACS analysis of SOX17 and FOXA2 in H1 hESCs treated with NT shRNA and
TRPM6 shRNAs and differentiated under AWS condition for 7 days. n = 3 independent
experiments.
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The fact that MEG functions specifically at the start of differentiation
inductions (Fig. 6A and B) also indicated that a transient knock down of the
true biological target of MEG, even if only during the onset of differentiation,
should be sufficient to phenocopy MEG, and should also represent a more
stringent test for the biological relevance of the target. A recently published
method which greatly boosted transient transfection efficiencies in hESCs by
the use of ROCK inhibitor Y-27632 has been applied to our experiments
(Yen et al., 2014) (Materials and Methods). As a result, TRPM6 knock [9_TD$DIFF]down
significantly enhanced the efficiencies of both mesoderm (Fig. 9D) and DE
(Fig. 9E) differentiations, whereas NEK3 knock down failed to offer any
significant enhancement effect in growth factor-induced mesoderm (Fig. 10A)
and DE (Fig. 10B) differentiations. These results, from a phenotypical
standpoint, confirmed that TRPM6 rather than NEK3 is most likely to be the
biological target of MEG.
[(Fig._10)TD$FIG]
Fig. 10. NEK3 is not the biological target of MEG. (A) FACS analysis of T and EOMES in H1
hESCs transfected with NT shRNA and NEK3 shRNAs and differentiated under A-BVF condition
for 2 days. Cells were plated at 0.5 × 105 cells/cm2. Cells cultured in mTeSR1 medium were used
as a gating control. n = 4 independent experiments. (B) FACS analysis of SOX17 and FOXA2 in
H1 hESCs transfected with NT shRNA and NEK3 shRNAs and differentiated under AWS condition
for 7 days. Cells were plated at 1.0 × 105 cells/cm2. Cells cultured in mTeSR1 medium were used
as a gating control. n = 2 independent experiments.
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2.6. Inhibitions of TRPM6/TRPM7 channel activity and
cellular Mg2+ uptake mimic the biological effect of MEG
As the best understood biological function of TRPM6 is in magnesium ion
transportation (Chubanov et al., 2005b; Chubanov et al., 2004; Schlingmann
et al., 2007), we set out to investigate the effect of MEG on cellular magnesium
homeostasis. Indeed, overnight incubation of MEG dramatically reduced
intracellular magnesium level in a dose dependent manner, as shown by flow
cytometry analysis using a magnesium sensor Mag-fluo-4 as indicator
(Fig. 11A). We thus hypothesized that MEG functions by inhibiting the
magnesium transport activity of TRPM6/TRPM7 channel, and tested this
hypothesis by examining whether other known TRPM6/TRPM7 channel
modulators or Mg2+-withdrawal can phenocopy MEG.
As a result, TRPM6/TRPM7 channel blocker Ruthenium Red (RR; 50 μM) and
modulator 2-aminoethoxydiphenyl borate (2-APB) (50 μM) significantly
enhanced mesoderm differentiation efficiency to a degree comparable to what
was observed in MEG (10 μM) treated samples (Fig. 11B); similar results were
obtained in DE differentiation (Fig. 11C). Note that the channel modulator
2-APB is known to increase TRPM6 but inhibit TRPM7 homo-tetrameric
channel activity at the micromolar level (Li et al., 2006), suggesting that the
inhibition of TRPM7 channel activity may have contributed more to the
biological phenotypes caused by MEG than TRPM6 channel inhibition.
Meanwhile, withdrawal of Mg2+ in mesoderm differentiation medium
dramatically enhanced growth factor-induced mesoderm differentiation to a
degree greater than that achieved by MEG treatment alone (74.3% versus 42.1%
T+EOMES+), whereas the combined treatment of MEG failed to further enhance
mesoderm differentiation efficiency on top of Mg2+-withdrawal (73.4% versus
74.3% T+EOMES+) (Fig. 11D), indicating that withdrawal of Mg2+ not only
phenocopied MEG but also rendered MEG-treatment ineffective for further
mesodermal induction. Similar results were observed in DE differentiation, with
Mg2+-withdrawal only during the first day of differentiation significantly
boosted the overall efficiency from 49.8% to 75.9% SOX17+FOXA2+
(Fig. 11E). Adding excess amount of Mg2+ in the differentiation medium to up
to 10 mM final concentration modestly reversed the differentiation enhancing
effects of MEG in both mesoderm (Fig. 11F) and DE (Fig. 11G)
differentiations, although never completely back to the same level as in the
control samples. Together these results demonstrated that MEG most likely
exerts its biological function by modulating TRPM6/TRPM7 channel activities
and, subsequently, cellular magnesium homeostasis.
Notably, both channel modulators and MEG significantly inhibited neural
differentiation activity induced by Dorsomorphin, a dual inhibitor of Nodal and
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[(Fig._11)TD$FIG]
Fig. 11. MEG functions by inhibiting cellular magnesium uptake. (A) FACS analysis of
magnesium sensor Mag-fluo-4 in H1 hESCs untreated (Control) or treated with various doses of
MEG overnight in mTeSR1 medium. n = 3 independent experiments. (B) FACS analysis of T and
EOMES in H1 hESCs differentiated under A-BVF condition for 2 days with or without the addition
of MEG (10 μM), 2-APB (50 μM), and Ruthenium Red (RR; 50 μM). Cells were plated at
0.5 × 105 cells/cm2. n = 4 independent experiments. (C) FACS analysis of SOX17 and FOXA2 in
two independent experiments of H1 hESCs pre-treated with DMSO, 10 μM MEG, and 50 μM
2-APB (top panel), and DMSO, 10 μM MEG, and 10 μM Ruthenium Red (RR) (bottom panel),
followed by DE differentiation under AWS condition for 7 days. n = 3 independent experiments.
(D) FACS analysis of T and EOMES in H1 hESCs differentiated under A-BVF condition with or
without MEG (10 μM) in regular medium or Mg2+-free medium for 2 days. n = 3 independent
experiments. (E) FACS analysis of SOX17 and FOXA2 in H1 hESCs differentiated under AWS
condition for 7 days in regular medium or Mg2+-free medium. n = 3 independent experiments.
(F) FACS analysis of T and EOMES in H1 hESCs differentiated under A-BVF condition for 2 days
with or without the addition of MEG (10 μM) and MEG+MgSO4 (1 mM and 10 mM). Cells were
plated at 0.5 × 105 cells/cm2. n = 2 independent experiments. (G) FACS analysis of SOX17 and
FOXA2 in H1 hESCs pre-treated with DMSO, MEG (10 μM), and MEG+MgCl2 (10 mM) followed
by AWS differentiation for 7 days. n = 2 independent experiments.
Article No~e00046
19 http://dx.doi.org/10.1016/j.heliyon.2015.e00046
2405-8440/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
BMP pathways (Zhou et al., 2010) (Materials and Methods) (Fig. 12A). This
result indicates that cellular magnesium level may have a differential regulatory
effect on neural differentiation as compared to mesoderm and DE
differentiations; specifically, a low level of cellular Mg2+ may be favorable to
mesendoderm differentiation while inhibitory to neuroectoderm differentiation
(Fig. 12B).
3. Discussion
In summary, this study demonstrated the nearly homogeneous derivations of
mesoderm and DE progenitors from hESCs enhanced by a novel small molecule
inhibitor MEG. Further investigations indicated that MEG performs its
biological function by targeting TRPM6/TRPM7 channels and subsequently
regulating cellular magnesium level, shedding light on a novel function of
magnesium during early embryonic development.
Extensive efforts were taken in this study to scrutinize the identities of the
differentiated progenies and to ensure accurate measurements of the differentiation
efficiencies in this study.Intracellular FACS staining of lineage-specific markers,
arguably one of the most accurate and discriminative method available for cell-fate
validation at the single cell level, was used as the primary method in this study to
distinguish and quantify the productions of mesoderm and DE progenitors. As a
technical note, many of the experiments conducted for the mechanism study of
MEG were not performed under optimum plating densities for the A-BVF- and
AWS-only conditions as determined in this report (Figs. 2B and 4B); rather they
were optimized for MEG and other treatment conditions in such a way that the
differentiation-enhancing effects of these treatments over the growth factor-only
conditions could be more clearly observed.
[(Fig._12)TD$FIG]
Fig. 12. A working model for a potential role of magnesium during cell fate specification.
(A) Western blotting of neural progenitor markers SOX1, PAX6, and SOX2 in H1 hESCs cultured in
neural differentiation medium for 7 days untreated (Control) or treated with Dorsomorphin
(1 μM). The Dorsomorphin treated samples were also incubated with DMSO, 2-APB (50 μM),
Ruthenium Red (RR; 50 μM), and MEG (10 μM), respectively. α-TUBULIN was used as a loading
control. n = 3 independent experiments. (B) Schematic representation of a working model summarizing
the findings of this study and suggesting a potential role of magnesium during cell fate specification.
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As MEG reduces intracellular level of Mg2+ (Fig. 11A), a cation essential for
normal cellular functions, it is worth examining whether MEG treatment leads
to cellular stress or toxicity. In our hands, we found that the cytotoxicity level
of MEG depended on several factors including plating density of the cells,
culture condition, treatment duration, and dosage. In general, MEG showed
higher toxicities when added to cells plated at lower densities. This density-
dependent toxicity was especially evident under DE induction condition; in fact,
MEG often caused non-negligible levels of toxicity to cells plated at or below
0.5 × 105 cells/cm2 for the pre-treatment condition, and for cells plated at
0.25 × 105 cells/cm2 for the combination condition of DE induction, giving rise
to large experimental variations, which was why these data points were
excluded from the summary table for DE induction efficiencies (Fig. 4B).
Compared to the DE induction condition, the mesoderm induction condition had
shown a much higher level of tolerance to MEG. MEG only started to show a
non-ignorable level of cytotoxicity at the lowest plating density tested
(0.1 × 105 cells/cm2) for mesoderm induction; it was also for this reason that
this data point was omitted from the mesoderm differentiation summary table
(Fig. 2B). The reason for this differential tolerance between mesoderm and DE
induction conditions is unknown. Predictably, prolonged treatments of MEG
caused higher levels of cytotoxicity; it was due to this reason that the dosage of
MEG was reduced to 1 μM for the combination condition of DE induction to
accommodate the longer treatment duration (7 days; Materials and Methods).
The exact mechanism of the molecular interaction between MEG and TRPM6
remains to be elucidated. As the kinases were bound by a non-specific kinase
inhibitor targeting their ATP-binding sites in the kinome screen, MEG may have
released TRPM6 by directly (sterically) competing with the ligand at its
ATP-binding site or by acting as an allosteric inhibitor. In depth biochemical or
computational analyses are granted to further characterize the nature of this
interaction. On the other hand, although TRPM7 was not included in the kinome
screen, it may also be a target of MEG due to its high sequence similarity with
TRPM6 (77%) (Nilius and Flockerzi, 2014). In fact, the result that the channel
modulator 2-APB, a potentiator of TRPM6 but an inhibitor of TRPM7
homo-tetrameric channel activity at the micromolar level (Li et al., 2006),
phenocopied MEG at a concentration of 50 μM, suggests that the inhibition of
TRPM7 channel activity may have contributed more to the biological function
of MEG than TRPM6 channel inhibition. The kinase domains of TRPM6 and
TRPM7 have both been reported to have regulatory roles over TRPM6/TRPM7
channel activities (Nilius and Flockerzi, 2014), which could offer an explanation
for the mechanism of action of MEG.
By studying the molecular mechanism underlying the function of MEG, we
have demonstrated a regulatory role of intracellular Mg2+ homeostasis during
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early embryonic cell fate determination in an in vitro cell culture system.
Despite limitations of an in vitro system, our findings may still offer insights
into the study of embryonic development in vivo. On the one hand, the fact that
MEG, TRPM6/TRPM7 channel blockers, and magnesium-withdrawal
simultaneously enhanced the inductions of both mesoderm and DE, the two
daughter lineages of primitive streak, indicates that a low intracellular level of
magnesium may be favorable to primitive streak formation during early
development. The fact that delayed treatment of MEG was ineffective also
indicates that this biological phenomenon may be most relevant during the
earliest onset of primitive streak induction in vivo. On the other hand, the fact
that MEG and the channel blockers inhibited neural differentiation (Fig. 12A)
indicates that a higher intracellular magnesium level may be a prerequisite of
neural induction. As briefly discussed in the Introduction, a previous study in
Xenopus laevis concluded that the underlying cause of the neural tube closure
defects induced by TRPM7 or Mg2+ depletion was the inhibition of
noncanonical Wnt pathway (PCP pathway) (Liu et al., 2011). However, in an
earlier work using mouse as a model (Walder et al., 2009), the authors claimed
to have never seen “an embryo with complete absence of neural tube closure” in
mice defective of TRPM6, and thus “the primary defect seems not to involve
disordered planar cell polarity”. Although still extremely preliminary, our result,
from a stem cell biologist's point of view, offers an alternative perspective for
the possible cause of this phenotype by showing that inhibition of cellular Mg2+
uptake may be, on a cellular level, inhibitory to neural differentiation
(Fig. 12A). These theories will remain as speculations until carefully examined
in an in vivo developmental system.
4. Materials and methods
4.1. Cell culture
H9 and H1 hESC lines (WiCell Research Institute, Madison, WI) and MMW2
hiPSCs (Mali et al., 2010) were maintained under a feeder condition or a
feeder-independent condition. For the feeder condition (Thomson et al., 1998),
primary mouse embryonic fibroblasts (MEFs) prepared from embryos of
pregnant CF-1 mice (day 13.5 of gestation; Charles River) were cultured in
DMEM containing 10% FBS (Hyclone), 1% non-essential amino acids (NEAA;
Invitrogen), and penicillin/streptomycin, and mitotically inactivated by gamma
irradiation. H9 and H1 hESCs and hiPSCs were cultured on irradiated MEFs in
media containing DMEM/F12, 20% knockout serum replacement (KSR;
Invitrogen), 4 ng/ml basic fibroblast growth factor (bFGF; Invitrogen),
1% NEAA, 1 mM glutamine, and 0.1 mM β-mercaptoethanol. For the
feeder-independent condition, hESCs and hiPSCs were cultured on Matrigel
(BD Biosciences)-coated plates in mTeSR1 medium (StemCell Technologies) as
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described (Ludwig et al., 2006). Experiments described in this study were
conducted with H9 and H1 hESCs between passages 30 and 60.
4.2. Small scale screening of mesoderm and DE inducers
Previously a high-throughput chemical screening was conducted at the
High-Throughput Screening Facility (HTSF) at the University of Illinois at
Urbana−Champaign (http://www.scs.illinois.edu/htsf/index.html). A total of
171,077 compounds from the Marvel Library, the HTSF House Library, the
ChemBridge MicroFormat Library, and the National Cancer Institute (NCI)
library were screened, giving rise to 29 bioactive small molecules which
potently disrupt hESC pluripotency (Geng et al., 2015). Using this collection
of 29 bioactive compounds, we conducted the small scale screen for mesoderm
and DE inducers. For this screen, hESCs were maintained in the pluripotent
state in mTeSR1 medium (Ludwig et al., 2006). Small molecules were added
at 1–10 μM, depending on their respective potencies and toxicities shown at
the validation stage of the previous high-throughput screen (Geng et al., 2015),
and incubated for 5–7 days to induce differentiation. Differentiated cultures
were then assayed for mesoderm, DE, and neural lineage-specific marker
expressions using Western blotting. Compounds that selectively induced the
expressions of mesoderm and DE markers, but not neural markers, were
identified as hits.
4.3. Mesoderm differentiation
To induce directed mesoderm differentiation, we used a growth-factor
combination (“A-BVF”), as previously reported with modifications (Bernardo
et al., 2011; Evseenko et al., 2010; Yu et al., 2011). H1 and H9 hESCs or
MMW2 hiPSCs were dissociated by Accutase (Invitrogen) and seeded onto
culture plates pre-coated with Matrigel (BD Biosciences) in mTeSR1 medium
(StemCell Technologies) supplemented with Y-27632 (10 μM; Calbiochem).
The day of seeding was referred to as “day -2”. On day 0, mTeSR1 medium
was replaced by a mesoderm induction medium, in which the basal medium
(Advanced RPMI-1640 basal medium supplemented with B-27 and Glutamax;
all from Invitrogen) was supplemented by Activin A (R&D Systems),
BMP4 (Invitrogen), human VEGF (Invitrogen), and bFGF (Invitrogen) (all at
10 ng/ml) from day 0 to day 1, while Activin A was removed from this
medium from day 1 to day 2. This protocol was referred to as the A-BVF
condition.
For MEG induction, MEG was either added to the mTeSR1 medium on day
“-1” as the “MEG->A-BVF” or “pre-treatment” condition (10 μM), or added to
the mesoderm induction medium as the “MEG+A-BVF” or “combination”
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condition (1, 5, or 10 μM). Cells were collected on day 1.5 to day 2 of this
protocol for further analyses.
Variations of mesoderm induction protocols used in this study include the “BVF”
condition with BMP4 (10 ng/ml), VEGF (10 ng/ml), and bFGF (20 ng/ml), and the
“BF” condition with BMP4 (10 ng/ml) and bFGF (20 ng/ml).
4.4. Definitive Endoderm differentiation
To induce definitive endoderm differentiation, we applied a method utilizing
Activin A, WNT3A and low concentrations of fetal bovine serum (FBS) which
was modified from previously reported methods (Borowiak et al., 2009;
D'Amour et al., 2005). H1 and H9 hESCs or MMW2 hiPSCs were seeded in the
same way as described for mesoderm differentiation, on day “-2”. On day 0,
mTeSR1 medium was replaced by an definitive endoderm induction medium, in
which a basal medium (Advanced RPMI-1640 medium supplemented by
Glutamax; Invitrogen) was supplemented by Activin A (50 or 100 ng/ml; from
day 0 to day 7), WNT3A (25 ng/ml; from day 0 to day 1) (R&D Systems),
0.2% FBS (from day 1 to day 2), and 2% FBS (from day 2 to day 7). This
protocol was referred to as the AWS condition.
For MEG induction, MEG was either added to the mTeSR1 medium at 10 μM
on day “-1” as the “MEG->AWS” or “pre-treatment” condition, or added to the
definitive endoderm induction medium at 1 μM throughout the course of
differentiation as the “MEG+AWS” or “combination” condition. Cells were
collected on day 5 of this protocol for qPCR analysis, and day 7 for Western
blotting or FACS analysis.
Variations of DE induction protocols used in this study include the “AW-B27”
condition in which FBS was replaced by 2% B-27 supplement (Invitrogen), the
“AW-ITS” condition in which FBS was replaced by Insulin-Transferrin-
Selenium supplement (ITS; Invitrogen) at concentrations of 0.1% from day 1 to
day 2 and 1% from day 2 to day 7, and the “AS” condition in which WNT3A
was removed from the growth factor combination.
4.5. Flow cytometry
Single cell suspensions were acquired through Accutase (Invitrogen) treatment.
Cells were fixed and stained using the Transcription Factor Buffer Set (BD
Biosciences) following the manufacturer's instructions. Conjugated antibodies
were used, including T-PE, EOMES-APC, FOXA2-Alexa488, and SOX17-APC
(all from R&D Systems; Table 1). Cells were resuspended in PBS supplemented
with 1% BSA and analyzed using a BD Biosciences LSR II flow cytometry
analyzer and BD FACSDiva software.
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4.6. KINOMEscan (DiscoveRx)
In this screen, DNA-tagged recombinant kinases were bound by ligands linked to a
solid support. When a small molecule inhibitor was added, it will bind to its target
kinase(s), either at the ligand-binding sites which directly competes with the
ligand, or at other parts of the protein which indirectly inhibits ligand-binding of
the kinase by inducing conformational changes. This inhibition will release the
target kinase of this small molecule from its ligand, and kinases released from the
solid support will be detected by PCR analysis through their DNA tags. Results for
binding interactions were reported as Percent of Control (%Ctrl): %Ctrl =
[(positive control signal – test compound signal)/(positive control signal – negative
control signal)] × 100. DMSO was used as negative control. Lower values of %
Ctrl indicate stronger interactions between the test compound and the kinases.
4.7. Western blotting
Cultured cells were lysed directly by 2× Laemmli buffer (Bio-Rad), boiled for
5 min, and analyzed using SDS-PAGE electrophoresis followed by wet-transfer
Table 1. Antibody sources and dilutions.
Antibody Source Catalog Number Dilution
OCT4 Santa Cruz sc-9081 1:1,000 (WB)
SOX2 Millipore AB5603 1:500 (WB)
α-TUBULIN Abcam ab11304 1:10,000 (WB)
GAPDH GeneScript A00192 1:10,000 (WB)
T R&D systems AF2085 1:500 (WB/IF)
EOMES Abcam ab23345 1:500 (WB/IF)
SOX17 R&D systems AF1924 1:500 (WB/IF)
FOXA2 Millipore 07-633 1:500 (WB/IF)
CER1 Thermo-Pierce MA5-15554 1:500 (WB)
AFP DAKO A0008 1:500 (WB)
SOX1 R&D systems AF3369 1:500 (WB)
PAX6 Covance PRB-278P 1:500 (WB)
T-PE R&D Systems IC2085P 1:20 (FACS)
EOMES-APC R&D Systems IC6166A 1:20 (FACS)
FOXA2-Alexa488 R&D Systems IC2400G 1:40 (FACS)
SOX17-APC R&D Systems IC1924A 1:20 (FACS)
Goat IgG-PE isotype control R&D Systems IC108P 1:20 (FACS)
Goat IgG-APC isotype control R&D Systems IC108A 1:20 (FACS)
Mouse IgG2B-APC isotype control BioLegend 400319 1:20 (FACS)
Goat IgG-Alexa488 isotype control R&D Systems IC108G 1:40 (FACS)
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onto nitrocellulose membranes using a system manufactured by Bio-Rad.
The membranes were blocked using blocking solution (5% BSA in Tris-buffered
saline containing 0.1% Tween-20 [TBST]), and then incubated with primary
antibodies (Table 1), diluted in TBST, at 4 °C overnight. The membranes were
then washed by TBST for 3 × 5 min, and incubated with horse radish
peroxidase (HRP) conjugated secondary antibodies at room temperature for 1 hr.
Finally, the membranes were washed 3–5 × 5 min by TBST and developed
using Super-Signal West Pico Chemiluminescent Substrate (Pierce).
4.8. Neural differentiation
Neural differentiation were conducted as previously reported (Zhou et al., 2010).
Briefly, hESCs were dissociated by Accutase (Invitrogen) and seeded onto
culture plates pre-coated with Matrigel (BD Biosciences) in mTeSR1 medium
(StemCell Technologies) supplemented with Y-27632 (10 μM; Calbiochem).
Cultures were let grow till complete confluency and then changed into neural
induction medium composed of Advanced DMEM/F12, 1% N-2 supplement,
and Glutamax (all from Invitrogen) and supplemented with or without
Dorsomorphin (1 μM; Sigma). Medium was changed every day. Cells were
collected on day 8 for analysis.
4.9. Immunofluorescent staining
Cells were washed once with phosphate-buffered saline (PBS) and fixed by 4%
paraformaldehyde (Santa Cruz) at room temperature for 20 min, permeabilized
by 0.5% Triton X-100 (Sigma) in PBS (PBST) for 15 min, and then blocked
with 5% donkey serum (Sigma) in 0.1% PBST at room temperature for 1 hr.
The samples were incubated with primary antibodies (Table 1) in 0.1% PBST at
4 °C overnight, washed three times by PBS, and then incubated with
fluorescent-labeled secondary antibodies in 0.1% PBST at room temperature for
2 hr. Finally, the cells were incubated with DAPI for 5 min, washed three times
by PBS, and subjected to fluorescent microscopy analysis (Zeiss).
4.10. RNA extraction, reverse transcription, and
quantitative-PCR
Total RNA were isolated using RNeasy mini kit (QIAGEN). cDNAs were
synthesized from the purified RNAs using Reverse Transcription System
(Promega). Quantitative-PCR was performed using QuantiTech SYBR Green
PCR kit (QIAGEN). Signals were analyzed using the comparative CT method,
and ACTB gene was used as an internal control. Primer sequences are listed in
Table 2.
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For TRPM6 isoform detection, cDNAs extracted from undifferentiated hESCs
were used as templates for PCR amplification of the isoforms followed by
agarose gel electrophoresis. For the sequences of isoform-specific PCR primers
see Chubanov et al. (Chubanov et al., 2004).
4.11. Fugene HD transfection
Fugene HD reagent was purchased from Promega. Transfections were conducted
following manufacturer's instructions. Briefly, plasmid DNA (Sigma TRC shRNA
vectors; Table 3) and Fugene HD transfection reagent were mixed at a 3:1 ratio in
Opti-MEM medium (Invitrogen), incubated 15 min at room temperature, and
applied to cells at day -1 or day 0 of the A-BVF or AWS differentiation protocols.
ROCK inhibitor Y-27632 was added during transfection to boost transfection
efficiency as previously reported (Yen et al., 2014).
4.12. Intracellular magnesium analysis
The cell permeant magnesium ion sensor Mag-fluo-4 was purchased from
Invitrogen. 10 μM Mag-fluo-4 was loaded into cells for 30 min at room
temperature in the dark, washed with PBS, and then analyzed using a BD
Biosciences LSR II flow cytometry analyzer and BD FACSDiva software.
Table 2. qPCR primers.
Primer Name Forward Primer (5′–3′) Reverse Primer (5′–3′)
ACTB agagctacgagctgcctgac cgtggatgccacaggact
T (Brachyury) gctgtgacaggtacccaacc catgcaggtgagttgtcagaa
EOMES gtggggaggtcgaggttc tgttctggaggtccatggtag
MIXL1 ggcgtcagagtgggaaatcc gcagttcacatctacctcaagag
EVX1 ttcacccgagagcagattg ccggttctggaaccacac
TBX6 gaacggcagaaactgtaagagg gtgtgtctccgctcccatag
HAND1 aaaggccctacttccagagc tgcgctgttaatgctctcag
MEOX1 aaagtgtcccctgcattctg cactccagggttccacatct
MESP1 ctgttggagacctggatgc cgtcagttgtcccttgtcac
SOX17 acgccgagttgagcaaga tctgcctcctccacgaag
FOXA2 tgggagcggtgaagatggaagggcac tcatgccagcgcccacgtacgacgac
CER1 acagtgcccttcagccagact acaactactttttcacagccttcgt
GSC gaggagaaagtggaggtctggtt ctctgatgaggaccgcttctg
GATA4 ggaagcccaagaacctgaat gttgctggagttgctggaa
GATA6 aatacttcccccacaacacaa ctctcccgcaccagtcat
AFP agcttggtggtggatgaaac ccctcttcagcaaagcagac
SOX7 ctcagggcagggaggtct gcactcggataaggagagtcc
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4.13. Statistical analysis
Statistical analyses were performed using Microsoft Excel.
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Table 3. Names and sequences of shRNAs.
Target shRNA Sequence (5′–3′)
TRPM6 TRPM6-1 ccggcctggcataaagaatgtatatctcgagatatacattctttatgccaggttttt
TRPM6-2 ccggccctctaatctaaagcgagttctcgagaactcgctttagattagagggttttt
TRPM6-3 ccggccaaattctaatggagtgtatctcgagatacactccattagaatttggttttt
TRPM6-4 ccgggctccctatctgataactcaactcgagttgagttatcagatagggagcttttt
NEK3 NEK3-1 ccgggcagtcccatagaacagaaatctcgagatttctgttctatgggactgcttttt
NEK3-2 ccggccttattatgtgcctccagaactcgagttctggaggcacataataaggttttt
NEK3-3 ccggcgaagcataacacaccaagaactcgagttcttggtgtgttatgcttcgttttt
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